# Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil

> **NCT05637710** · PHASE3 · WITHDRAWN · sponsor: **Eurofarma Laboratorios S.A.**

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Administration of investigation of Eurofarma drug
- **DRUG:** Administration of Comparator

## Key facts

- **NCT ID:** NCT05637710
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-03
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic change in development priorities
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05637710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05637710, "Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05637710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*